The injectable nature of GLP-1 RAs presents both challenges and opportunities for clinics: Challenges: Patient anxiety about self-injection, training requirements, cost of devices Opportunities: Regular contact with healthcare providers, controlled dispensing, ability to monitor adherence Administration Methods: Glutathione Unlike GLP-1 receptor agonists, glutathione can be administered through multiple routes, each with distinct advantages and considerations: 1
GlyNAC (glycine and N-acetylcysteine) supplementation in mice increases length of life by correcting glutathione deficiency, oxidative stress, mitochondrial dysfunction, abnormalities in mitophagy and nutrient sensing, and genomic damage
How soon will I notice results
This hypothesis that PL induced human pancreatic cancer cell death mainly via the induction of ROS-mediated ferroptosis, on the grounds that the cell death could be suppressed by ferroptosis inhibitors (ferrostatin-1 and liproxstatin-1) and the iron chelator deferoxamine (DFO) (Yamaguchi et al., 2018)
GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective